Back to Search
MARK EFFRON, M.D.
M.D.
Cardiovascular Disease Physician
NPI: 1598139362IndividualAccepts Medicare
Specialties, Licenses & Credentials
Cardiovascular Disease PhysicianPrimary
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
300981(LA)
CMS Specialties
PrimaryCARDIOVASCULAR DISEASE (CARDIOLOGY)
Education
JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE
Class of 1978
Research & Publications (18)
Effects of the selective estrogen receptor modulator raloxifene on coronary outcomes in the Raloxifene Use for The Heart trial: results of subgroup analyses by age and other factors.
PMID 19204301·Circulation·2009
2-rct
Treating patients with 'wake-up' stroke: the experience of the AbESTT-II trial.
PMID 18772451·Stroke·2008
4-observational
Facilitated PCI in patients with ST-elevation myocardial infarction.
PMID 18499565·N Engl J Med·2008
4-observational
Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II).
PMID 18032739·Stroke·2008
3-trial
The effect of tadalafil on the time to exercise-induced myocardial ischaemia in subjects with coronary artery disease.
PMID 16236035·Br J Clin Pharmacol·2005
4-observational
Impact of in-hospital acquired thrombocytopenia in patients undergoing primary angioplasty for acute myocardial infarction.
PMID 16098296·Am J Cardiol·2005
3-trial
Physical and chemical compatibility of drotrecogin alfa (activated) with 34 drugs during simulated Y-site administration.
PMID 15646701·Am J Health Syst Pharm·2004
8-other
Feasibility and implications of an early discharge strategy after percutaneous intervention with abciximab in acute myocardial infarction (the CADILLAC Trial).
PMID 14516875·Am J Cardiol·2003
3-trial
Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial.
PMID 12939213·Circulation·2003
3-trial
A current review of olanzapine's safety in the geriatric patient: from pre-clinical pharmacology to clinical data.
PMID 11748788·Int J Geriatr Psychiatry·2001
6-review
Abciximab readministration: results of the ReoPro Readministration Registry.
PMID 11514371·Circulation·2001
3-trial
Abciximab and bleeding during coronary surgery: results from the EPILOG and EPISTENT trials. Improve Long-term Outcome with abciximab GP IIb/IIIa blockade. Evaluation of Platelet IIb/IIIa Inhibition in STENTing.
PMID 10969673·Ann Thorac Surg·2000
8-other
Abciximab, ticlopidine, and concomitant abciximab-ticlopidine therapy: ex vivo platelet aggregation inhibition profiles in patients undergoing percutaneous coronary interventions.
PMID 10966553·Am Heart J·2000
3-trial
Platelet glycoprotein IIb/IIIa receptor antagonists and their use in elderly patients.
PMID 10803858·Drugs Aging·2000
6-review
Zn2+ inhibits alpha-ketoglutarate-stimulated mitochondrial respiration and the isolated alpha-ketoglutarate dehydrogenase complex.
PMID 10788456·J Biol Chem·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1514 JEFFERSON HWY
NEW ORLEANS, LA 70121 - Phone
- (317) 997-0334
Quick Facts
- NPI
- 1598139362
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 48
- Publications
- 18
Are you this provider?
Claim Your Profile